JeffreyE.LeeMD
General Surgery • Houston, TXSurgical Oncology (Other than Breast)
Professor of Surgery, University Tex Houston
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1991 - 1993
Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1989 - 1991- Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1984 - 1987
Stanford University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1985 - Present
FL State Medical License 2021 - Present
GA State Medical License 2022 - 2026
AZ State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
OK State Medical License 2020 - 2025- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Publications & Presentations
PubMed
- Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy.Madeline B Torres, Jessica E Maxwell, Rebecca A Snyder, Hop S Tran Cao, Michael P Kim
Annals of Surgical Oncology. 2024-12-01 - Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways.Ahad Azimuddin, Ching-Wei D Tzeng, Laura R Prakash, Morgan L Bruno, Elsa M Arvide
Journal of the American College of Surgeons. 2024-04-01 - Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.Samuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, Jessica Maxwell, Rebecca A Snyder
Annals of Surgery. 2024-03-20
Journal Articles
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaShubham Pant, Milind Javle, Naruhiko Ikoma, Ching-Wei Tzeng, Jeffrey E Lee, JAMA Surgery
- Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right HepatectomyJose M Soliz, Claudius Conrad, Jeffrey E Lee, Annals of Surgical Oncology
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Join now to see all
Authored Content
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
Press Mentions
Best of the Best in Care: Meet Houston's Top Doctors 2016October 21st, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
